Reinterpreting the efficacy of <scp>IL</scp> ‐1 inhibitors in <scp>VEXAS</scp> syndrome: a matter of superiority or sequencing?: comment on the article by Eviatar et al
Disclosure Form Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Authors
- Zhenguo Ding
- Tiantian Zhang (ORCID: https://orcid.org/0000-0001-7127-8593)
- S. Zhang (ORCID: https://orcid.org/0009-0007-8242-0867)
Institutions
- Jining Traditional Chinese Medicine Hospital (CN)
- Zhejiang Provincial People's Hospital (CN)
Publication Details
- Journal
- Arthritis & Rheumatology
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1002/art.70006
- Primary Topic
- Otitis Media and Relapsing Polychondritis
- Type
- article
- Field-Weighted Citation Impact
- 0.00